- Activities: Hybrid Community/VHA Oncology Forums: Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer , Improving Patient Outcomes With Novel Therapies for Relapsed/Refractory Multiple Myeloma, PARP Inhibitors for Metastatic Prostate Cancer: Integrating New Agents into Practice, Targeting EGFR Alterations at Exons 19 and 21 in Patients With Non-Small Cell Lung Cancer: Bringing Therapeutic Advances Into the Clinic, Hybrid Community/VHA Oncology Forums: Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer, Hybrid Community Oncology Forums: Improving Patient Outcomes via Systemic Therapies for Unresectable Hepatobiliary Carcinoma, The 35th International Prostate Cancer Update (IPCU 35), Virtual Journal Club: Latest Updates and Peer-to-Peer Discussions in DR/DME and AMD Management - Diabetic Retinopathy Trends and Disparities in Younger Patients: The Implications for Managed Care, PayerTalkCE Presents: Case Challenge: Age-Related Macular Degeneration, Hybrid Community Hematology/Oncology Forums: Recent Advances in the Frontline Treatment of FLT3-Mutated Acute Myeloid Leukemia, Understanding the Patient Journey for Better Outcomes in Retinal Disease - Encore, Optimizing Personalized Care of Veterans With CLL or MCL Using BTK Inhibitors in the Frontline and Relapsed/Refractory Settings, Breaking the Relapse Cycle: LAIs in Schizophrenia Management, Managed Care Review Board Presents: Managed Care Strategies to Optimize Overall Outcomes in Multiple Myeloma, Treatment Strategies Across the Spectrum of Prostate Cancer: Impact of New Agents and Combination Therapies for Urologists, PayerTalkCE Presents: Managing DR/DME for Underserved Populations, PayerTalkCE Presents: Care Coordination for a Patient with AMD and Multiple Comorbid Conditions, What s New in Myeloproliferative Neoplasms? An Update on Polycythemia Vera and Essential Thrombocythemia, Understanding the Patient Journey for Better Outcomes in Retinal Disease, EGFR Exon 19 and 21 Alterations in Non-Small Cell Lung Cancer: Recent Therapeutic Advances and Implications for Care, Novel Strategies in Mantle Cell Lymphoma: A Focus on BTK Inhibitors in the Front Line, Hybrid Community Oncology Forums: Improving Patient Outcomes via Chimeric Antigen Receptor T (CAR T) -Cell Therapy in Relapsed/Refractory Multiple Myeloma - Empowering Peer-to-Peer Education, Improving Alzheimer s Disease Treatment at the VA: Early Diagnosis and Disease-Modifying Therapies, Hybrid Oncology Clinical Forums: Advanced Non-Melanoma Skin Cancer in Patients: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes, Internal Medicine for Primary Care: Allergy & Immuno/Endo/Geri/Nephro, Empowering Community Clinicians to Provide Expert Localized Care for Patients with Myelofibrosis and Anemia, Applying Regional Health Plan Best Practices in the Treatment of AMD and DR/DME, Geriatric Medicine for Primary Care: Cardio/Geri/Vasc, Internal Medicine for Primary Care: Cardio/Neuro/Onc, Internal Medicine for Primary Care: Derm/Gastro/Medicolegal/Pulm, Internal Medicine for Primary Care: Gastro/Pulm/Vasc, Office Orthopedics for Primary Care, Internal Medicine for Primary Care: Endo/Gyn/Rheum/Sleep, Internal Medicine for Primary Care: Derm/Neuro/Pain/Psych, Diabetic Retinopathy/Diabetic Macular Edema (DR/DME) - Payer Implications Fact Sheet, AGE-RELATED MACULAR DEGENERATION (AMD) PAYER IMPLICATIONS FACT SHEET, CAR T-Cell Therapies for B-Cell Lymphoma in the Community Setting: Empowering Peer-to-Peer Education, PayerTalkCE Presents: Diabetes Quality Management Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy, Key Insights Infographic: Assessing Recent Advances for Enhanced Management of Retinal Diseases, ManagedCareEye.com Presents: Managed Care Review Board - Assessing Recent Advances for Enhanced Management of Retinal Diseases, Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Integrating Recent Advances into Evolving Treatment Paradigms, The Frontline of Alzheimer's Care Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy, Doc to Doc Series, Category II Action Plan (CAP note), Management of Category II Fetal Heart Tracing, Interpretation of Fetal Cord Gas, Category II Fetal Heart Tracings, PayerTalkCE Presents: Unmet Needs in AMD and DME Podcast, Emerging Advances in Immune Checkpoint Inhibitors as Neoadjuvant and/or Adjuvant Therapy in Early-Stage NSCLC, Targeting and Treating EGFR Exon 19 and 21 Alterations in Non-Small Cell Lung Cancer, PayerTalkCE Presents: Innovations in the Retinal Disease Treatment Paradigm Podcast, ManagedCareEye.com Presents: Addressing the Clinical Burden of DR/DME A 55-Year-Old Female with Type 2 Diabetes and Worsening Vision, Advancing Care: No Longer Settling for "Enough" Enhancing Treatment of Hormone-Sensitive Prostate Cancer, MangedCareEye.com Presents: Treatments for Age-Related Macular Degeneration (AMD) – 58-Year-Old Female with Hypertension, Hyperlipidemia, and Long-term Smoking History, ManagedCareEye.com Presents: Retinopathy of Prematurity (ROP) – Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area, Optimizing Therapy for Low-risk MyelodysplasticSyndromes in Community Practice, PayerTalkCE™ Presents: Continuous Glucose Monitoring: Improving Access to CGM Under the Pharmacy Benefit, Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Track 3: Spotlight on Retinal Vein Occlusion, Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Track 2: Spotlight on Age-Related Macular Degeneration, PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP) Podcast, PayerTalkCE Presents: Interpreting A Complex Puzzle: US Commercial Payer Coverage of Atopic Dermatitis (AD) Treatments Varies Widely
- Provider Ship: 1
- Provider Address: Englewood, CO, USA
- Activity Link: http://www.cmepartner.org
- Number of Activities Reported Last Year: 1016
- Name of Contact: Nathan AScott
- Phone Number: (303) 578-0416
- Address: 384 Inverness Parkway, Suite 230, Englewood, CO, 80112, USA
- Accreditation Status: Joint Accreditation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Journal CME/CE, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply